Accepted for/Published in: Online Journal of Public Health Informatics
Date Submitted: Jul 22, 2023
Open Peer Review Period: Jul 20, 2023 - Sep 14, 2023
Date Accepted: Aug 4, 2024
(closed for review but you can still tweet)
Implementation of E-pharmacy in India – Facilitators, barriers, and its potential impact on cost, quality, and access to medicines: A scoping review
ABSTRACT
Background:
E-pharmacy can potentially solve problems related to the quality of services and products, cost and access to medicines in low and middle-income countries. The present review aims to understand the facilitators and barriers to the implementation of E-pharmacy in India.
Objective:
The present scoping review was undertaken (i) to understand the facilitators and barriers for use of E-pharmacy in India and (ii) to estimate the potential for E-Pharmacy in India for improving access to medication, improving the quality of services and medicines, and decreasing costs of medications
Methods:
All published and grey literature from July 1, 2011, to June 30, 2021, relating to E-pharmacy, was searched from Medline, Scopus, ProQuest, and Google using a systematic search strategy.
Results:
In total, 1464 titles and abstracts were screened of which 47 full texts were included in the review. E-pharmacy can potentially improve access to medications for remote areas, and old and debilitated individuals. E-pharmacies can enable lean supply chain management, lower cost, and allow easy tracking of dispensed medicines. There is potential for integration of E-pharmacy services into the national program of Bhartiya Jan Aushadhi Pariyojana. However, the country is not adequately regulated to prevent the growth of illicit pharmacies. Lack of global accreditation and internet coverage, digital literacy, and transnational access are other challenges.
Conclusions:
E-pharmacy has the potential to improve universal health coverage in India by improving access to medicines and lowering the overall cost of healthcare. However, future growth will need specific regulations and accreditation mechanisms. Clinical Trial: Protocol registered on Open Science Forum https://doi.org/10.17605/OSF.IO/6R9YQ
Citation
The author of this paper has made a PDF available, but requires the user to login, or create an account.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.